Methylpyrrolidone

Methylpyrrolidone

SCHEMBL7540126

CN1CCCC1=O.ClCCl

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.81
BRD2 P25440 1/20 0.81
PIK3CD O00329 2/20 0.42
INMT O95050 2/20 0.41
LMNA P02545 3/20 0.39
KMT2A Q03164 4/20 0.37
TSHR P16473 2/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA3 P07451 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA13 Q8N1Q1 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CA5B Q9Y2D0 1/20 0.36
MEN1 O00255 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylpyrrolidone SCHEMBL6590411 0.93 BRD4 (0.77) BRD4BRD2PIK3CDINMTLMNA
Methylpyrrolidone SCHEMBL3306767 0.92 BRD4 (0.68) BRD4BRD2PIK3CDINMTLMNA
Methylpyrrolidone SCHEMBL5423326 0.90
Methylpyrrolidone SCHEMBL487 0.90
Methylpyrrolidone SCHEMBL1255511 0.90 BRD4 (1.00) BRD4BRD2PIK3CDINMTLMNA
Methylpyrrolidone SCHEMBL8055062 0.90 BRD4 (1.00) BRD4BRD2PIK3CDINMTLMNA
Methylpyrrolidone SCHEMBL28183883 0.88
Methylpyrrolidone SCHEMBL9634127 0.88
Methylpyrrolidone SCHEMBL27899870 0.88 BRD4 (0.85) BRD4BRD2PIK3CDINMTLMNA
Methylpyrrolidone SCHEMBL10902634 0.88 BRD4 (0.85) BRD4BRD2PIK3CDINMTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10414766-B2 Polymorph of Riociguat and its process for the preparation ALEMBIC PHARMACEUTICALS LIMITED (IN) 2019-09-17 US claimed
US-20190002461-A1 NOVEL POLYMORPH OF RIOCIGUAT AND ITS PROCESS FOR THE PREPARATION ALEMBIC PHARMACEUTICALS LIMITED (IN) 2019-01-03 US claimed
WO-2017103760-A1 NOVEL POLYMORPH OF RIOCIGUAT AND ITS PROCESS FOR THE PREPARATION ALEMBIC PHARMACEUTICALS LIMITED (IN) 2017-06-22 WO claimed
US-20130123499-A1 Method for Purifying a Fused Pyrrolocarbazole Derivative CEPHALON FRANCE (FR) 2013-05-16 US claimed
JP-11035705-A None JP disclosed
CN-113804737-B Polyaniline loaded silver/cuprous oxide multi-element nanocomposite and preparation method of modified electrode 宁德师范学院 2024-02-13 CN disclosed
EP-4204089-A1 CHEMICAL PROBES AND INHIBITORS FOR POLYPEPTIDES OF SARS CORONAVIRUSES Universität Konstanz (DE) 2023-07-05 EP disclosed
CN-113804738-B Polyaniline-loaded cuprous oxide sensing electrode and preparation thereof 宁德师范学院 2023-04-25 CN disclosed
CN-113804738-A Polyaniline-loaded cuprous oxide sensing electrode and preparation thereof 宁德师范学院 2021-12-17 CN disclosed
CN-113804737-A Preparation method of polyaniline-loaded silver/cuprous oxide multi-element nano composite material and modified electrode 宁德师范学院 2021-12-17 CN disclosed
CN-110514726-B Fe-PANI/Au modified electrode for sensitive detection of dopamine and uric acid and preparation thereof 宁德师范学院 2021-08-13 CN disclosed
CN-110514725-B Fe-PANI-based dopamine electrochemical sensing electrode and preparation thereof 宁德师范学院 2020-12-11 CN disclosed
US-6284036-B1 PIGMENTING POROUS SINTERED MATERIAL COMPRISING BORIDE, CARBIDE, SILICIDE, NITRIDE OR PHOSPHIDES BY APPLYING SOLUTION OF SOLUBLE PIGMENT DERIVATIVE AND REGENERATING ORGANIC PIGMENT BY HEATING TO DEPOSIT PIGMENT IN PORES CIBA SPECIALTY CHEMICALS CORPORATION 2001-09-04 US disclosed
EP-0975600-A1 HETEROCYCLIC DERIVATIVES AND THEIR USE AS ANTITHROMBOTIC AGENTS Akzo Nobel N.V. (NL) 2000-02-02 EP disclosed
JP-H1135705-A PRODUCTION OF POLYETHERSULFONE RESIN FILM SUMITOMO CHEM CO LTD 1999-02-09 JP disclosed
WO-1998047876-A1 HETEROCYCLIC DERIVATIVES AND THEIR USE AS ANTITHROMBOTIC AGENTS AKZO NOBEL N.V. (NL) 1998-10-29 WO disclosed
WO-1997004770-A1 2-(FLUORENONYL)-CARBAPENEMS, COMPOSITIONS AND METHODS OF USE MERCK & CO., INC. (US) 1997-02-13 WO disclosed
US-5451579-A 1-β-methyl-carbapenem, compositions containing same and methods of use MERCK & CO., INC. (US) 1995-09-19 US disclosed
WO-1995021841-A1 1-β-METHYL-CARBAPENEM, COMPOSITIONS CONTAINING SAME AND METHODS OF USE MERCK & CO., INC. (US) 1995-08-17 WO disclosed
US-4113680-A Method for preparing 17 α-ester-21-halo pregnanes TAISHO PHARMACEUTICAL CO., LTD. (JP) 1978-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190002461-A1 NOVEL POLYMORPH OF RIOCIGUAT AND ITS PROCESS FOR THE PREPARATION RIOK1, RIOK2, RIOK3 BRD4 4863/4885BRD2 4867/4885PIK3CD 2442/4885
US-10414766-B2 Polymorph of Riociguat and its process for the preparation RIOK2, RIOK1, RIOK3 BRD4 4877/4885BRD2 4878/4885PIK3CD 2600/4885
US-20130123499-A1 Method for Purifying a Fused Pyrrolocarbazole Derivative PYCR1, PGA5, PAICS BRD4 259/4885BRD2 1258/4885PIK3CD 2407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.